Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Monthly Archives: July 2016

Tufts CSDD Report: Cost of Bringing New Drug to Market Surpasses $2.8 Billion.

Lab 3 VerticalBoston, MA, July 22, 2016 — The most recent analysis by the Tufts Center for the Study of Drug Development of the average cost to develop and gain marketing approval for a new drug — pegged at $2.558 billion — was published in the May issue of Journal of Health Economics.

The article contains more detailed analyses and discussion than were presented in November 2014 when Tufts CSDD first disclosed primary results on the cost of developing a new prescription medicine, after having previously submitted the study to the peer-reviewed publication.

The $2.558 billion figure per approved compound is based on estimated average out-of-pocket costs of $1.395 billion and time costs (expected returns that investors forego while a drug is in development) of $1.163 billion. Continue reading

Neuroscience Milestone: Updated Brain Map Identifies Nearly 100 Previously Unknown Regions

Brain new scan 2016New York, NY, July 21, 2016 ― Carl Zimmer reports in The New York Times that the brain looks like a featureless expanse of folds and bulges, but it’s actually carved up into invisible territories.

Each is specialized: Some groups of neurons become active when we recognize faces, others when we read, others when we raise our hands.

On July 20, in what many experts are calling a milestone in neuroscience, researchers published a spectacular new map of the brain, detailing nearly 100 previously unknown regions — an unprecedented glimpse into the machinery of the human mind. Continue reading

Acting Governor Guadagno Announces Record Number of New NJ Businesses in 2015

Acting Governor Kim Guadagno

Acting Governor Kim Guadagno

Trenton, NJ, July 21, 2016 ― A sign of continued positive trends in New Jersey’s economy, Acting Governor Kim Guadagno yesterday announced the number of new businesses that filed to start operations in New Jersey last year soared to a record 97,835, the highest level in state history, New Jersey Business reports.

The 2015 level is higher than 2014, when 94,898 new businesses were formed, and continues the upward momentum of new filings since the start of the Christie Administration in 2010 when there were 80,773 new filings, according to the New Jersey Department of the Treasury.

“I am proud to announce that 2015 was a record year for business growth in New Jersey,” Acting Governor Guadagno said.  “More than 97,000 new businesses filed to begin work in our state last year which marks the highest level in New Jersey history.” Continue reading

Has Zika Arrived in U.S.? Florida Investigates Possible First Homegrown Case

Zika 3Washington, DC, July 20, 2016 ― Sabrina Tavernise reports in The New York Times that the Florida Department of Health said Tuesday that it was investigating what could be the first homegrown case of the Zika virus in the United States.

The department said in a statement that it was investigating a “possible non-travel-related” case in Miami-Dade County.

The department is “actively conducting an epidemiological investigation” and is collaborating with the Centers for Disease Control and Prevention, the statement said.  No further details were available. Continue reading

House Ways and Means Chair Won’t Back Trump on Negotiating Medicare Drug Prices

Medicare Part D 1Washington, DC, July 20, 2016 ― Sarah Ferris reports in The Hill that U.S. House Ways and Means Committee Chairman Kevin Brady (R-Texas) on Tuesday shot down one of Donald Trump’s most high-profile healthcare pitches: allowing Medicare to negotiate prescription drug prices.

When asked at a healthcare panel at the Republican National Convention if he would back Trump’s proposal, Chairman Brady flatly said, “No,” prompting laugher in the room, according to Ferris.

“Study after study shows that that will save no money,” Brady told the panel. Continue reading

With Millions Covered Under Obamacare,’ the Republicans’ Repeal and Replace’ Gets Riskier

Obamacare REPEALWashington, DC, July 20, 2016 ― The Associated Press reports in The New York Times that as Republicans gathered to anoint their presidential ticket in Cleveland, uncompromising opposition to “Obamacare” is getting politically riskier.

Few people were covered under President Barack Obama’s health care law when the GOP held its last convention in 2012.  Now, Donald Trump’s plan to replace the program would make 18 million people uninsured, according to a recent nonpartisan analysis.

Reviled as it may be, Obama’s law has changed the nation in ways that many may not want reversed.   Continue reading

Governor Christie Announces Departure of Long-Serving Labor Commissioner Harold Wirths

Harold Wirths

Harold Wirths

Trenton, NJ, July 19, 2016 — Governor Chris Christie yesterday announced the departure of one of his longest serving cabinet members, Labor Commissioner Harold J. Wirths, who has been at the helm of the Department of Labor and Workforce Development since February 2010 and who will leave office next month.

The Governor will be nominating Commissioner Wirths to serve on the State Parole Board.

“I am grateful for the dedication and strong sense of public service Hal has brought to my administration,” said Governor Christie.  “He demonstrated great leadership during an economic downturn when our Unemployment Insurance Trust Fund was bankrupt and the Great Recession hit its peak.” Continue reading

Val Skinner Foundation Commits to Multi-Year Funding of Decoding Cancer Program with Discovery Education

Cancer wordsBay Head, NJ, July 19, 2016 ― For the 17th consecutive year, some of the LPGA’s biggest stars gathered in New Jersey to raise funds for the Val Skinner Foundation, bringing the 17-year total to more than $10.5 million raised for scientific research, early detection and educational programs.

The LIFE Event (LPGA Pros in the Fight to Eradicate breast cancer) was held today at Mountain Ridge Country Club in West Caldwell, NJ.

Earlier this year, former LPGA player Val Skinner, in collaboration with the LIFE Center at Rutgers Cancer Institute of New Jersey, partnered with Discovery Education, the leading provider of digital content for K-12 classrooms, to develop an interactive biology and genetics education program supporting the study of cancer in high school classrooms. Continue reading

GEN Publishes 2016 Top 10 U.S. Biopharma Clusters List; New Jersey/New York Ranked No. 3

New Jersey map magnify - cropNew Rochelle, NY, July 19, 2016Genetic Engineering & Biotechnology News (GEN) in May published its 2016 Top 10 US Biopharma Clusters list.  New Jersey/New York is number three on the list, the same position it was on GEN’s 2015 Top 10 list.

This year’s Top 10 are:

  1. Boston-Cambridge
  2. San Francisco Bay Area
  3. New Jersey/New York
  4. Maryland/DC Metro
  5. San Diego
  6. Greater Philadelphia
  7. Seattle
  8. Raleigh/Durham
  9. Los Angeles/Orange County
  10. Chicagoland Continue reading

Stevens Center for Healthcare Innovation Helps Tackle Social Needs in Medical Technology Development

Stevens Institute of TechnologyHoboken, NJ, July 19, 2016 ― A significant gift from an alumnus will serve as a powerful growth engine for the three-year-old Center for Healthcare Innovation at Stevens Institute of Technology in Hoboken, New Jersey.

Created in 2013 as a vehicle to improve medical technology and healthcare delivery, the Stevens Center for Healthcare Innovation intersects the fields of medicine, engineering and science by sponsoring research, building partnerships, commercializing intellectual property and creating curricula to strengthen skill gaps in the workforce.

Today, more than 60 university faculty from diverse academic disciplines are affiliated with the Center for Healthcare Innovation, tackling unmet needs in medical technology and major issues. Continue reading